Zobrazeno 1 - 10 of 17 pro vyhledávání: '"V N, Nasonov"'
1
[Effect of piperacillin/tazobactam on the anti-infection resistance in patients with infections in the peritoneal cavity]
Autor: K I, Savitskaia, A I, Lobakov, A M, Savov, E V, Rusanova, V N, Nasonov, T V, Chernen'kaia, T A, Silkina
Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 42(2)
The effect of the monotherapy with piperacillin/tazobactam (P/T) or tazocin on microflora of the mucous membranes of the nose and pharynx of 33 patients and the contents of the large intestine of 21 patients as well as on the immunological aspects (c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a40893f6cae6012d9141a9108a8ec3bf
https://pubmed.ncbi.nlm.nih.gov/9124993
Zobrazit plný text záznamu
2
[Use of piperacillin-tazobactam in abdominal surgery]
Autor: A M, Savov, K I, Savitskaia, A I, Lobakov, N V, Klimonova, V N, Nasonov
Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 42(2)
Piperacillin/tazobactam (P/T) was used in the monotherapy of 40 patients with various inflammatory diseases of the abdominal cavity organs. P/T was administered as dropwise intravenous infusions in a single dose of 4/0.5 g 3 times a day for 5 to 17 d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b332c9b877ffbcc973acc68dba4c81a7
https://pubmed.ncbi.nlm.nih.gov/9124990
Zobrazit plný text záznamu
3
[A method of sequential (intravenous and oral) use of ofloxacin in the treatment of patients with infections of organs of the peritoneal cavity]
Autor: K I, Savitskaia, A I, Lobakov, A M, Savov, T V, Chernen'kaia, V N, Nasonov, E V, Rusanova, T A, Silkina
Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 41(9)
Clinico-laboratory estimation of the efficacy and tolerance of ofloxacin used in succession, at first intravenously and then orally, in the treatment of 15 patients with infection of the abdominal cavity was performed. It was shown that after the use
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f365eb3b2a15c142232885517c38e640
https://pubmed.ncbi.nlm.nih.gov/9005790
Zobrazit plný text záznamu
4
[Ciprofloxacin in the treatment of chronic bacterial prostatitis]
Autor: M F, Trapeznikova, K I, Savitskaia, A, al-Suri, A G, Nekhorosheva, N S, Abramian, V N, Nasonov
Publikováno v: Urologiia i nefrologiia. (5)
17 exacerbation and 13 latent CBP cases received ciprofloxacin in a dose 500 mg twice a day orally for 6-34 days. At pretreatment microbiological investigation of the prostatic juice 49 cultures of 7 microorganism species were isolated (12 cases of m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fe6467fe624770b901cdb33d2cd20ebf
https://pubmed.ncbi.nlm.nih.gov/8571477
Zobrazit plný text záznamu
5
[Use of ofloxacin in the treatment of infections of the lower respiratory tract]
Autor: K I, Savitskaia, L N, Tsar'kova, A G, Shanina, V N, Nasonov, O E, Solodilova, E V, Rusanova
Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 39(6)
The taxonomy of the causative agents of lower respiratory tract infections (LRTI) isolated from patients in the Moscow Region was studied and the clinico-microbiological efficacy and tolerance of ofloxacin used in their treatment were estimated. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ae4e975cc3fe80b87af455e06ccddd2c
https://pubmed.ncbi.nlm.nih.gov/7848003
Zobrazit plný text záznamu
7
[Thienam (imipenem/cilastatin) as an agent for empirical antibiotic therapy]
Autor: K I, Savitskaia, V N, Nasonov, A G, Nekhorosheva, A G, Shanina
Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 38(12)
The clinicobacteriological efficacy and tolerance of thienam (imipenem/cylastatin) were studied in the empirical therapy of 38 patients with severe purulent inflammatory diseases of various localization i.e. pneumonia, lung abscesses, pyothorax, peri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9c4635bd0f428231183fa7847fea50d5
https://pubmed.ncbi.nlm.nih.gov/8085905
Zobrazit plný text záznamu
8
[A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria]
Autor: K I, Savitskaia, A G, Nekhorosheva, L Z, Skala, V N, Nasonov, O E, Solodilova, A G, Shanina, E N, Dutova
Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 37(9)
Augmentin suspension (amoxycillin+clavulanic acid) was estimated in clinico-laboratory studies with respect to children suffering from pyoinflammatory diseases of various localization and its high efficacy was shown. Good and satisfactory results wer
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dc834259e37c7189b36711127723fe25
https://pubmed.ncbi.nlm.nih.gov/1444666
Zobrazit plný text záznamu
10
[Pharmacokinetic monitoring during aminoglycosides: optimal therapy method of individual amikacin dosing]
Autor: A A, Firsov, V N, Nasonov, L A, Golovleva
Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 36(11)
One of the most successful approaches to adjustment of dosage regimens on the basis of single determinations of drug contents in blood specimens provides the blood sampling at the "ideal" moment (t*), i. e. at the time equal to the inverse value of t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dc927a1fbddafa342226a146b74980f0
https://pubmed.ncbi.nlm.nih.gov/1793295
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje